Expertise in
6
conditions

Oriol Sibila

Barcelona, CT, ES 
Expertise in
6
conditions
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Oriol Sibila practices in Barcelona, Spain. Sibila is highly rated in 6 conditions, according to our data. Their top areas of expertise are Bronchiectasis, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), and Pseudomonas Stutzeri Infections.

Their clinical research consists of co-authoring 144 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Barcelona, CT, Spain
Other Locations
Madrid, MD, Spain
Spain
Pau, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia
Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Drug
Study Drug: Budesonide
Study Phase: Phase 4
View 1 Less Clinical Trial

144 Total Publications

Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Journal: American journal of respiratory and critical care medicine
Published: February 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sibila's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile